Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study

Metformin and spironolactone alone can be used for the management of polycystic ovarian syndrome (PCOS), and their combination could result in even better outcomes. To compare the effects and safety of low-dose spironolactone combined with metformin or either drug alone on insulin resistance (IR) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Tao, Zhang, Ying, Zeng, Chunping, Zheng, Siyuan, Zhou, Lin, Liu, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957463/
https://www.ncbi.nlm.nih.gov/pubmed/35345424
http://dx.doi.org/10.1155/2022/9927240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957463/
https://www.ncbi.nlm.nih.gov/pubmed/35345424
http://dx.doi.org/10.1155/2022/9927240

Ejemplares similares